Antibiotics, also known as antibacterials, are given to destroy or slow down the growth of bacteria.
Therefore, diseases that are caused by bacteria can effectively be cleared up – including strep throat, UTIs, and other infections, like gonorrhoea.
To understand why viruses – like the common cold and Covid – aren’t cleared up the same way, we need to explore the biological differences in bacteria and viruses.
Viruses are an assembly of different types of molecules that consist of genetic material (either a single- or double-stranded DNA or RNA) with a protein coat.
- Neuroscience Breakthrough: Study Pinpoints Brain Activity That Helps Prevent Us From Getting Lost
- Brief Anger Hampers Blood Vessel Function Leading to Increased Risk of Heart Disease and Stroke – New Study
- New Blood Test Pinpoints Future Stroke Risk – Study Identifies Inflammatory Molecules as Key Biomarker
- Enceladus: A Potential Haven for Extraterrestrial Life in its Hidden Ocean Depths
- New Experiment: Dark Matter Is Not As ‘DARK’ As All We Think
Viruses are sometimes enveloped with a layer of fat too, including SARS-CoV-2 (which causes Covid).
This protective coating is one reason antibiotics don’t work. Unlike bacteria, viruses don’t have cell walls that can be attacked by antibacterials.
However, as much as the coat can make the virus harder to target, it can also help: the reason why washing our hands is effective in slowing down the spread of Covid is because the fatty layer is disrupted by the soap, breaking down the virus.
The other reason why antibiotics don’t work is because of how viruses work in comparison to bacteria.
Unlike bacteria, which attack your body’s cells from the outside, viruses move into and make copies of themselves in your body’s cells.
Viruses attach to healthy cells and reprogram those cells to make new viruses.
What are antivirals?
With all that said, how will the Pfizer pill help?
The Pfizer pill is an example of an antiviral – and it is hoped the drug, named PF-07321332, will prevent severe illness and serve as a second line of defence if new vaccine-resistant strains of Covid emerge.
Trials of the new drug have been underway in subjects aged between 18 and 60, at two anonymous Pfizer buildings in the US and Belgium – with hopes that if it proves successful, the drug could spell an end to future lockdowns.
Antivirals work by interfering with an enzyme of a virus which then keeps the virus from escaping from one cell to infect another.
So it doesn’t ‘cure’ the virus, per se, but if taken early enough, it can stop the virus from spreading and worsening.
- Neuroscience Breakthrough: Study Pinpoints Brain Activity That Helps Prevent Us From Getting Lost
- Brief Anger Hampers Blood Vessel Function Leading to Increased Risk of Heart Disease and Stroke – New Study
- New Blood Test Pinpoints Future Stroke Risk – Study Identifies Inflammatory Molecules as Key Biomarker
- Enceladus: A Potential Haven for Extraterrestrial Life in its Hidden Ocean Depths
- New Experiment: Dark Matter Is Not As ‘DARK’ As All We Think
Mikael Dolsten, M.D., chief scientific officer and president of worldwide research, development, and medical at Pfizer said it is possible that the new drug could be prescribed “at the first sign of infection, without requiring that patients are hospitalized or in critical care.”
Image Credit: iStock
